These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 17038832)

  • 61. Advances in RSV vaccine research and development - A global agenda.
    Higgins D; Trujillo C; Keech C
    Vaccine; 2016 Jun; 34(26):2870-2875. PubMed ID: 27105562
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Respiratory syncytial virus vaccine: where are we now and what comes next?
    Noor A; Krilov LR
    Expert Opin Biol Ther; 2018 Dec; 18(12):1247-1256. PubMed ID: 30426788
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The burden of RSV-associated illness in children aged < 5 years, South Africa, 2011 to 2016.
    Moyes J; Tempia S; Walaza S; McMorrow ML; Treurnicht F; Wolter N; von Gottberg A; Kahn K; Cohen AL; Dawood H; Variava E; Cohen C
    BMC Med; 2023 Apr; 21(1):139. PubMed ID: 37038125
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The immunogenicity and safety of respiratory syncytial virus vaccines in development: A systematic review.
    Shan J; Britton PN; King CL; Booy R
    Influenza Other Respir Viruses; 2021 Jul; 15(4):539-551. PubMed ID: 33764693
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Burden and Cost of Hospitalization for Respiratory Syncytial Virus in Young Children, Singapore.
    Tam CC; Yeo KT; Tee N; Lin R; Mak TM; Thoon KC; Jit M; Yung CF
    Emerg Infect Dis; 2020 Jul; 26(7):1489-1496. PubMed ID: 32568036
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effects of human metapneumovirus and respiratory syncytial virus antigen insertion in two 3' proximal genome positions of bovine/human parainfluenza virus type 3 on virus replication and immunogenicity.
    Tang RS; Schickli JH; MacPhail M; Fernandes F; Bicha L; Spaete J; Fouchier RA; Osterhaus AD; Spaete R; Haller AA
    J Virol; 2003 Oct; 77(20):10819-28. PubMed ID: 14512532
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Potential impact of a maternal vaccine for RSV: A mathematical modelling study.
    Hogan AB; Campbell PT; Blyth CC; Lim FJ; Fathima P; Davis S; Moore HC; Glass K
    Vaccine; 2017 Oct; 35(45):6172-6179. PubMed ID: 28967522
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Clinical analysis of children with pertussis and significance of respiratory virus detection in the combined diagnosis].
    Huang H; Deng L; Xiao F; Fu J; Deng J; Wang F; Yang J
    Zhonghua Er Ke Za Zhi; 2017 Aug; 55(8):580-585. PubMed ID: 28822432
    [No Abstract]   [Full Text] [Related]  

  • 69. Prevention of serious respiratory syncytial virus-related illness. I: Disease pathogenesis and early attempts at prevention.
    Groothuis JR; Hoopes JM; Jessie VG
    Adv Ther; 2011 Feb; 28(2):91-109. PubMed ID: 21318606
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clinical and economic outcomes associated with respiratory syncytial virus vaccination in older adults in the United States.
    Herring WL; Zhang Y; Shinde V; Stoddard J; Talbird SE; Rosen B
    Vaccine; 2022 Jan; 40(3):483-493. PubMed ID: 34933763
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Global Disease Burden Estimates of Respiratory Syncytial Virus-Associated Acute Respiratory Infection in Older Adults in 2015: A Systematic Review and Meta-Analysis.
    Shi T; Denouel A; Tietjen AK; Campbell I; Moran E; Li X; Campbell H; Demont C; Nyawanda BO; Chu HY; Stoszek SK; Krishnan A; Openshaw P; Falsey AR; Nair H;
    J Infect Dis; 2020 Oct; 222(Suppl 7):S577-S583. PubMed ID: 30880339
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Attenuated Human Parainfluenza Virus Type 1 Expressing the Respiratory Syncytial Virus (RSV) Fusion (F) Glycoprotein from an Added Gene: Effects of Prefusion Stabilization and Packaging of RSV F.
    Liu X; Liang B; Ngwuta J; Liu X; Surman S; Lingemann M; Kwong PD; Graham BS; Collins PL; Munir S
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28835504
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Respiratory syncytial virus infection in Guatemala, 2007-2012.
    McCracken JP; Prill MM; Arvelo W; Lindblade KA; López MR; Estevez A; Müller ML; Muñoz F; Bernart C; Cortez M; Moir JC; Ortíz J; Paredes A; Iwane MK
    J Infect Dis; 2013 Dec; 208 Suppl 3():S197-206. PubMed ID: 24265479
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Respiratory syncytial virus--the unrecognised cause of health and economic burden among young children in Australia.
    Ranmuthugala G; Brown L; Lidbury BA
    Commun Dis Intell Q Rep; 2011 Jun; 35(2):177-84. PubMed ID: 22010512
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Ongoing developments in RSV prophylaxis: a clinician's analysis.
    Rezaee F; Linfield DT; Harford TJ; Piedimonte G
    Curr Opin Virol; 2017 Jun; 24():70-78. PubMed ID: 28500974
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Clinical and epidemiologic features of respiratory syncytial virus.
    Hall CB; Simőes EA; Anderson LJ
    Curr Top Microbiol Immunol; 2013; 372():39-57. PubMed ID: 24362683
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Respiratory syncytial virus hospitalisations among young children: a data linkage study.
    Prasad N; Newbern EC; Trenholme AA; Wood T; Thompson MG; Aminisani N; Huang QS; Grant CC
    Epidemiol Infect; 2019 Jan; 147():e246. PubMed ID: 31364578
    [TBL] [Abstract][Full Text] [Related]  

  • 78. An evaluation of the emerging interventions against Respiratory Syncytial Virus (RSV)-associated acute lower respiratory infections in children.
    Nair H; Verma VR; Theodoratou E; Zgaga L; Huda T; Simões EA; Wright PF; Rudan I; Campbell H
    BMC Public Health; 2011 Apr; 11 Suppl 3(Suppl 3):S30. PubMed ID: 21501449
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clinical Endpoints for Respiratory Syncytial Virus Prophylaxis Trials in Infants and Children in High-income and Middle-income Countries.
    Simões EA; Carbonell-Estrany X; Guilbert T; Mansbach JM; Piedra PA; Ramilo O; Welliver R
    Pediatr Infect Dis J; 2015 Oct; 34(10):1086-92. PubMed ID: 26121204
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Hospitalization due to respiratory syncytial virus infection in patients under 2 years of age with hemodynamically significant congenital heart disease.
    Andres S; Bauer G; Rodríguez S; Novali L; Micheli D; Fariña D
    J Pediatr (Rio J); 2012 May; 88(3):246-52. PubMed ID: 22718202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.